Valued at $181.5M at its later-stage round, Nov 2023. Nothing has traded since.
- ·Watch Aro Biotherapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Aro Biotherapeutics funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2022 | Early Stage VC | $24.0M | ▮ | ▮ |
| Dec 2020 | Later Stage VC | $90.3M | ▮ | ▮ |
| Dec 2019 | Early Stage VC | $5.0M | ▮ | ▮ |
| Mar 2019 | Seed Round | $3.5M | ▮ | ▮ |
Membership and data by Private Market View
Aro Biotherapeutics valuation
Aro Biotherapeutics was valued at $182 million at its later-stage round in Nov 2023. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Aro Biotherapeutics raised?
Aro Biotherapeutics has raised $132 million across 4 recorded rounds since 2019. The largest was a $90.3 million later-stage round in Dec 2020; the most recent was a $24 million early-stage round in Dec 2022.
Aro Biotherapeutics has filed 7 Form Ds with the SEC since 2019, most recently in Dec 2022 ($24 million sold to 12 investors).
How Aro Biotherapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Aro Biotherapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Aro Biotherapeutics
- What is Aro Biotherapeutics worth?
- Aro Biotherapeutics is valued at $181.5M as of Oct 2026. Valued at $181.5M at its later-stage round, Nov 2023. Nothing has traded since.
- How much has Aro Biotherapeutics raised?
- Aro Biotherapeutics has raised $131.8M in total funding across 4 recorded rounds.
- When did Aro Biotherapeutics last raise?
- Aro Biotherapeutics last raised in Dec 2022 (Early Stage VC), raising $24.0M.